These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015]. Aguilera-Alonso D; López Ruiz R; Centeno Rubiano J; Morell García M; Valero García I; Ocete Mochón MD; Montesinos Sanchis E An Pediatr (Engl Ed); 2019 Jul; 91(1):21-29. PubMed ID: 30679135 [TBL] [Abstract][Full Text] [Related]
3. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534 [TBL] [Abstract][Full Text] [Related]
4. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children. Lung DC; Yip EK; Lam DS; Que TL Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339 [TBL] [Abstract][Full Text] [Related]
5. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy. Lung DC; Chan YH; Kwong L; Que TL Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480 [TBL] [Abstract][Full Text] [Related]
6. Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland. Meyer Sauteur PM; Bleisch B; Voit A; Maurer FP; Relly C; Berger C; Nadal D; Bloemberg GV Swiss Med Wkly; 2014; 144():w14041. PubMed ID: 25254315 [No Abstract] [Full Text] [Related]
7. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Gardiner SJ; Gavranich JB; Chang AB Cochrane Database Syst Rev; 2015 Jan; 1(1):CD004875. PubMed ID: 25566754 [TBL] [Abstract][Full Text] [Related]
8. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Mulholland S; Gavranich JB; Gillies MB; Chang AB Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of general and severe mycoplasma pneumoniae pneumonia in children. Yang S; Lu S; Guo Y; Luan W; Liu J; Wang L BMC Infect Dis; 2024 Apr; 24(1):449. PubMed ID: 38671341 [TBL] [Abstract][Full Text] [Related]
10. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Mulholland S; Gavranich JB; Chang AB Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439 [TBL] [Abstract][Full Text] [Related]
11. Mycoplasma and Chlamydia pneumonia in pediatrics. Nelson CT Semin Respir Infect; 2002 Mar; 17(1):10-4. PubMed ID: 11891514 [TBL] [Abstract][Full Text] [Related]
12. A study of community-acquired Yu HX; Zhao MM; Pu ZH; Ju YR; Liu Y Colomb Med (Cali); 2018 Jun; 49(2):160-163. PubMed ID: 30104808 [TBL] [Abstract][Full Text] [Related]
13. [The epidemiological characteristics and drug resistance of mycoplasma pneumoniae in patients with community-acquired pneumonia during 2011-2015 in 5 sentinel hospitals in Beijing]. Shi WX; Wu SS; Gong C; Li AH; Huang F Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Sep; 51(9):832-836. PubMed ID: 28881550 [No Abstract] [Full Text] [Related]
14. Outbreak of macrolide-resistant mycoplasma pneumoniae in a primary school in Beijing, China in 2018. Zhang WZ; Zhang SJ; Wang QY; Li YD; Jing HB; Hu GY; Wu D BMC Infect Dis; 2019 Oct; 19(1):871. PubMed ID: 31640591 [TBL] [Abstract][Full Text] [Related]
15. Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma pneumoniae Infection in Children With Community-Acquired Pneumonia. Meyer Sauteur PM; Theiler M; Buettcher M; Seiler M; Weibel L; Berger C JAMA Dermatol; 2020 Feb; 156(2):144-150. PubMed ID: 31851288 [TBL] [Abstract][Full Text] [Related]
16. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood]. Ouchi K Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195 [TBL] [Abstract][Full Text] [Related]
18. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. Morozumi M; Takahashi T; Ubukata K J Infect Chemother; 2010 Apr; 16(2):78-86. PubMed ID: 20094751 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology and Molecular Characteristics of Mycoplasma pneumoniae During an Outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome. Watkins LKF; Olson D; Diaz MH; Lin X; Demirjian A; Benitez AJ; Winchell JM; Robinson CC; Bol KA; Glodé MP; Dominguez SR; Miller LA; Kutty PK Pediatr Infect Dis J; 2017 Jun; 36(6):564-571. PubMed ID: 28060039 [TBL] [Abstract][Full Text] [Related]